Michal Arkuszewski
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Effect of Erenumab on Patient-Reported Outcomes in Episodic Migraine in Asia, the Middle East, and Latin America: Results From the EMPOwER Study.
Journal: Neurology. Clinical practice
Published: September 10, 2024
Efficacy and Safety of Erenumab in Participants With Episodic Migraine in Whom 2-4 Prior Preventive Treatments Had Failed: LIBERTY 3-Year Study.
Journal: Neurology
Published: April 26, 2024
Reversibility of cognitive worsening observed with BACE inhibitor umibecestat in the Alzheimer's Prevention Initiative (API) Generation Studies.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: April 26, 2024
Effect of erenumab on the reversion from chronic migraine to episodic migraine in an Asian population: A post hoc analysis of the DRAGON study.
Journal: Headache
Published: December 22, 2023
Serum tau protein elevation in migraine: a cross-sectional case-control study.
Journal: The journal of headache and pain
Published: July 17, 2023
A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study.
Journal: The journal of headache and pain
Published: July 08, 2022
Bimagrumab to improve recovery after hip fracture in older adults: a multicentre, double-blind, randomised, parallel-group, placebo-controlled, phase 2a/b trial.
Journal: The lancet. Healthy longevity
Published: November 26, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026